Polyrizon announces receipt of nasdaq delisting notice

Raanana, israel, may 23, 2025 (globe newswire) -- polyrizon ltd. (nasdaq: plrz) (the “company” or “polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the listing qualifications department of the nasdaq stock market llc (“nasdaq”), stating that based on its review of the company's public filings with the securities and exchange commission (the “sec”), its staff has determined to delist the company's securities pursuant to its discretionary authority under listing rule 5101. the receipt of the nasdaq notification letter does not result in the immediate delisting of the company's ordinary shares and has no current immediate effect on the listing or trading of the company's ordinary shares on the nasdaq capital market, under symbol “plrz.”
PLRZ Ratings Summary
PLRZ Quant Ranking